Involvement of AMP‐activated protein kinase in neuroinflammation and neurodegeneration in the adult and developing brain
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Microglial activation followed by neuroinflammation is a defense mechanism of the brain to eliminate harmful endogenous and exogenous materials including pathogens and damaged tissues, while excessive or chronic neuroinflammation may cause or exacerbate neurodegeneration observed in brain injuries and neurodegenerative diseases. Depending on conditions/environments during activation, microglia acquire distinct phenotypes, such as pro‐inflammatory, anti‐inflammatory, and disease‐associated phenotypes, and show their ability to phagocytose various objects and produce pro‐and anti‐inflammatory mediators. Prevention of excessive inflammation by regulating the microglia's pro/anti‐inflammatory balance is important for alleviating progression of brain injuries and diseases. Among many factors involved in the regulation of microglial phenotypes, cellular energy status plays an important role. Adenosine monophosphate‐activated protein kinase (AMPK), which serves as a master sensor and regulator of energy balance, is considered a candidate molecule. Accumulating evidence from adult rodent studies indicates that AMPK activation promotes anti‐inflammatory responses in microglia exposed to danger signals or various stressors mainly through inhibition of the nuclear factor κB (NF‐κB) signaling and activation of the nuclear factor erythroid‐2‐related factor‐2 (Nrf2) pathway. However, AMPK activation in neurons exposed to stressors/insults may exacerbate neuronal damage if AMPK activation is excessive or prolonged. While AMPK affects microglial activation states and neuronal cell survival rates in both the adult and the developing brain, studies in the developing brain are still scarce, even though activated AMPK is highly expressed especially in the neonatal brain. More in depth studies in the developing brain are important, because neuroinflammation/neurodegeneration occurred during development can result in long‐lasting brain damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“…at P5, microglia start engulfing inappropriate pre-synaptic elements via interactions between microglia and unwanted synapses through classical complement cascade with complement proteins C1q and C3 as identification signals (Stephan et al., 2012; Schafer et al., 2012; Bialas and Stevens, 2013).”
BackgroundRetractedAMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · cited 1×
“…is different from that of a microglial population uniquely associated with neurodegenerative diseases (Sousa et al., 2018) and called disease associated microglia (DAM) or microglial neurodegenerative (MGnD) phenotypes (Keren-Shaul et al., 2017; Krasemann et al., 2017; Shi and Holtzman, 2018).”
BackgroundMicroglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 2×
“…activates or inhibits several protein targets via deacetylation of histones and non-histone proteins, and SIRT1 deacetylates and inactivates the p65 component of the NF-κB pathway, thus limiting the expression of NF-κB-dependent genes and suppressing inflammatory responses (Yeung et al., 2004).”
BackgroundHammond, T. R., Dufort, C., Dissing-Olesen, L., Giera, S., Young, A., Wysoker, A., Walker, A. J., Segel, M., Nemesh, J., Saunders, A., et al. (2018) · doi:10.1101/406140 · Cited by 2,225
Microglial M1/M2 polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070 · cited 8×
“4 on microglia, activate a transcription factor NF-ĸB, and enhance expression of proinflammatory cytokines, chemokines, and cytotoxic factors, such as tumor necrosis factor α (TNF-α), interleukin-1 β (IL1β), TLRs, cytokine receptors, nitric oxide, and reactive oxygen species (ROS) (Lehnardt et al., 2003, 2002; Akira a…”
BackgroundMethodInfluentialShaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
Neuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed
Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-98 · Cited by 1,748 · cited 3×
“…using nomenclatures of macrophages: classical proinflammatory (M1) and alternate anti-inflammatory (M2) phenotypes (Orihuela et al., 2016; Cherry et al., 2014b; Hu et al., 2015; Jha et al., 2016), although this classification is only one of the designation systems for characterizing…”
BackgroundLKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650
Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589 · cited 3×
“…protein kinases; LKB1 that is constitutively active (Hawley et al., 2003; Woods et al., 2003; Shaw et al., 2004), calmodulin kinase kinase β (CaMKKβ) (Hawley et al., 2005; Oakhill et al., 2012), and the transforming growth factor-β activated kinase (TAK1) (Momcilovic et al., 2006), 2)…”
BackgroundInfluentialA polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263 · cited 5×
“also involved in both energy metabolism and inflammation in microglia (Zhang et al., 2017; Vilhardt et al., 2017; Ulland et al., 2017).”
BackgroundInfluentialDamage-associated molecular patterns in inflammatory diseases
Roh, J. S., & Sohn, D. H. (2018) · Immune Network · doi:10.4110/in.2018.18.e27 · Cited by 1,261
Microglia development follows a stepwise program to regulate brain homeostasis
Matcovitch-Natan, O., Winter, D. R., Giladi, A., Vargas Aguilar, S., Spinrad, A., Sarrazin, S., Ben-Yehuda, H., David, E., Zelada González, F., Perrin, P., et al. (2016) · Science · doi:10.1126/science.aad8670 · Cited by 1,180
Metabolism of Inflammation Limited by AMPK and Pseudo-Starvation
O'Neill, L. A. J., & Hardie, D. G. (2013) · Nature · doi:10.1038/nature11862 · Cited by 1,133
The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease
Stephan, A. H., Barres, B. A., & Stevens, B. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113810 · Cited by 1,113
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Structure of mammalian AMPK and its regulation by ADP
Xiao, B., Sanders, M. J., Underwood, E., Heath, R., Mayer, F. V., Carmena, D., Jing, C., Walker, P. A., Eccleston, J. F., Haire, L. F., et al. (2011) · Nature · doi:10.1038/nature09932 · Cited by 926 · cited 1×
“…and 3) activation of LKB1-induced Thr172 phosphorylation by AMP binding to γ subunit and inhibition of protein phosphatase-2Cα (PP2C-α)-induced Thr172 dephosphorylation by AMP or ADP binding to γ subunit (Hardie et al., 2016; O’Neill and Hardie, 2013; Xiao et al., 2007, 2011; Gowans et al., 2013).”
BackgroundAMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs
Hardie, D. G., Schaffer, B. E., & Brunet, A. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.013 · Cited by 859 · cited 12×
“…which acts to restore energy homeostasis by activating catabolic pathways that generate ATP and by inhibiting anabolic pathways that consume ATP (Hardie et al., 2016, 2012), indirectly inhibits NF-κB activation through multiple downstream pathways including SIRT1, Folkhead box O (FOXO), and…”
BackgroundInfluentialRegulation of innate immune responses in the brain
Rivest, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2565 · Cited by 843 · cited 1×
“Microglial activation and neuroinflammation in the brain are the innate immune processes to defend the brain against harmful agents, such as bacterial and viral pathogens and dead cells and injured tissues (Rivest, 2009).”
BackgroundLayer V cortical neurons require microglial support for survival during postnatal development
Ueno, M., Fujita, Y., Tanaka, T., Nakamura, Y., Kikuta, J., Ishii, M., & Yamashita, T. (2013) · Nature Neuroscience · doi:10.1038/nn.3358 · Cited by 781 · cited 3×
“…zone seems to enhance neurogenesis and oligodendrogenesis through production of several cytokines (Shigemoto-Mogami et al., 2014), and the survival of layer V cortical neurons requires microglia, which are accumulated close to the subcerebral region and secrete IGF1 (Ueno et al., 2013).”
BackgroundInfluentialSIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740 · cited 2×
“Resveratrol, a potent SIRT1 activator, ameliorates LPS-induced NF-κB activation in mouse hippocampus (Ge et al., 2015), and activation of SIRT1 markedly reduces NF-κB signaling and shows strong neuroprotection against amyloid β toxicity in primary cortical cultures (Chen et al., 2005).”
BackgroundResveratrol stimulates AMP kinase activity in neurons
Dasgupta, B., & Milbrandt, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610068104 · Cited by 723 · cited 2×
“AMPK has been observed not only in the peripheral tissues but also in hypothalamic neurons, cortical neurons, and Neuro2a cells (Dasgupta and Milbrandt, 2007; Landree et al., 2004).”
BackgroundFilipello, F., Morini, R., Corradini, I., Zerbi, V., Canzi, A., Michalski, B., Erreni, M., Markicevic, M., Starvaggi-Cucuzza, C., Otero, K., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.016 · Cited by 695
Mammalian AMP-activated protein kinase subfamily
Stapleton, D., Mitchelhill, K. I., Gao, G., Widmer, J., Michell, B. J., Teh, T., House, C. M., Fernandez, C. S., Cox, T., Witters, L. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.611 · Cited by 652 · cited 1×
“AMPK is a heterotrimer consisting of a catalytic subunit (α1 or α2) coupled to two regulatory subunits (β1 or β2; γ1, γ2, or γ3), which is ubiquitously expressed in mammalian cells (Hardie et al., 2016; Stapleton et al., 1996).”
BackgroundErblich, B., Zhu, L., Etgen, A. M., Dobrenis, K., & Pollard, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026317 · Cited by 649 · cited 2×
“velopment including behavioral defects (Erblich et al., 2011; Rosin et al., 2018), while microglial loss in adulthood seems to have little impact on behavioral outcomes (Lenz and Nelson, 2018).”
BackgroundPrenatal Poly(I:C) Exposure and Other Developmental Immune Activation Models in Rodent Systems
Meyer, U. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.011 · Cited by 626 · cited 2×
“…activation of microglia during embryonic and neonatal periods seems to induce neurodevelopmental abnormalities: Prenatal exposure of rodents to influenza, Poly(I:C), or LPS increases cytokines such as IL-1β, TNF-α, IL6 and induces neurodevelopmental abnormalities in the offspring (Meyer, 2014).”
BackgroundStructural basis for AMP binding to mammalian AMP-activated protein kinase
Xiao, B., Heath, R., Saiu, P., Leiper, F. C., Leone, P., Jing, C., Walker, P. A., Haire, L., Eccleston, J. F., Davis, C. T., et al. (2007) · Nature · doi:10.1038/nature06161 · Cited by 591 · cited 1×
“…and 3) activation of LKB1-induced Thr172 phosphorylation by AMP binding to γ subunit and inhibition of protein phosphatase-2Cα (PP2C-α)-induced Thr172 dephosphorylation by AMP or ADP binding to γ subunit (Hardie et al., 2016; O’Neill and Hardie, 2013; Xiao et al., 2007, 2011; Gowans et al., 2013).”
BackgroundA novel microglial subset plays a key role in myelinogenesis in developing brain
Wlodarczyk, A., Holtman, I. R., Krueger, M., Yogev, N., Bruttger, J., Khorooshi, R., Benmamar‐Badel, A., de Boer‐Bergsma, J. J., Martin, N. A., Karram, K., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696056 · Cited by 535 · cited 1×
“It has been also indicated that a CD11c-positive microglial subset, which is the major source of IGF-1, displays myelinogenic and neurogenic phenotypes (Wlodarczyk et al., 2017).”
BackgroundGowans, G. J., Hawley, S. A., Ross, F. A., & Hardie, D. G. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.019 · Cited by 531 · cited 1×
“…and 3) activation of LKB1-induced Thr172 phosphorylation by AMP binding to γ subunit and inhibition of protein phosphatase-2Cα (PP2C-α)-induced Thr172 dephosphorylation by AMP or ADP binding to γ subunit (Hardie et al., 2016; O’Neill and Hardie, 2013; Xiao et al., 2007, 2011; Gowans et al., 2013).”
BackgroundNorden, D. M., Muccigrosso, M. M., & Godbout, J. P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.028 · Cited by 413 · cited 8×
“neurodegeneration is induced or enhanced by neuroinflammation as predicted in some neurodegenerative diseases and brain injuries (Block et al., 2007; Norden et al., 2015; Colonna and Butovsky, 2017), AMPK activation may exert neuroprotection by attenuating neuroinflamma-”
BackgroundInfluentialMungai, P. T., Waypa, G. B., Jairaman, A., Prakriya, M., Dokic, D., Ball, M. K., & Schumacker, P. T. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05124-11 · Cited by 385
Culmsee, C., monnig, J., Kemp, B. E., & Mattson, M. P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:1:45 · Cited by 340
Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke
McCullough, L. D., Zeng, Z., Li, H., Landree, L. E., McFadden, J., & Ronnett, G. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409985200 · Cited by 333 · cited 2×
“Therefore, AMPK activation is recognized as the development of neurological disorders, although it is unclear whether this activation is beneficial or deleterious (McCullough et al., 2005).”
BackgroundYamanaka, M., Ishikawa, T., Griep, A., Axt, D., Kummer, M. P., & Heneka, M. T. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1569-12.2012 · Cited by 326 · cited 2×
“…promotes phagocytosis of apoptotic cells, contributing to the resolution of inflammation (Flores et al., 2016; Savage et al., 2015; Villapol, 2018; Yamanaka et al., 2012; Zhao et al., 2015b), although there is a report showing that an antagonist of PPARγ promotes the pro-inflammatory to…”
BackgroundSingle‐cell transcriptomics reveals distinct inflammation‐induced microglia signatures
Sousa, C., Golebiewska, A., Poovathingal, S. K., Kaoma, T., Pires‐Afonso, Y., Martina, S., Coowar, D., Azuaje, F., Skupin, A., Balling, R., et al. (2018) · The EMBO Reports · doi:10.15252/embr.201846171 · Cited by 281
Danger-associated molecular patterns in Alzheimer’s disease
Venegas, C., & Heneka, M. T. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0416-204r · Cited by 236 · cited 2×
“Neuroprotection by AMPK observed in some of the in vivo disease/ injury models may block microglial proinflammatory activation, which can be triggered by receiving danger signals from damaged neurons (Roh and Sohn, 2018; Venegas and Heneka, 2017; Schindler et al., 2018).”
BackgroundAMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration
Peixoto, C. A., Oliveira, W. H. D., Araújo, S. M. D. R., & Nunes, A. K. S. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.013 · Cited by 196
AMPK β1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance
Dzamko, N., van Denderen, B. J. W., Hevener, A. L., Jørgensen, S. B., Honeyman, J., Galic, S., Chen, Z.-P., Watt, M. J., Campbell, D. J., Steinberg, G. R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056762 · Cited by 175 · cited 1×
“However, it has also been shown that AMPK β-/- mice display no visible brain developmental deficits (Dzamko et al., 2010), and using transgenic mice that are ubiquitously inactivated for the AMPKα1 gene and conditionally inactivated for the AMPKα2 gene, it has been indicated that AMPK is not…”
BackgroundNuclear Receptors License Phagocytosis by Trem2+Myeloid Cells in Mouse Models of Alzheimer's Disease
Savage, J. C., Jay, T., Goduni, E., Quigley, C., Mariani, M. M., Malm, T., Ransohoff, R. M., Lamb, B. T., & Landreth, G. E. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4586-14.2015 · Cited by 154 · cited 4×
“highly involved in energy metabolism, is suggested to be a key regulator of anti-inflammatory functions of microglia (Flores et al., 2016; Savage et al., 2015; Yamanaka et al., 2012; Zhao et al., 2015b).”
BackgroundInfluentialO’Loughlin, E., Pakan, J. M. P., Yilmazer-Hanke, D., & McDermott, K. W. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0981-8 · Cited by 127 · cited 1×
“Acute exposure to LPS in prenatal mice induces inflammation and alters glial cytoarchitecture in the P40 brain (O’Loughlin et al., 2017).”
BackgroundWilliams, T., Courchet, J., Viollet, B., Brenman, J. E., & Polleux, F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013660108 · Cited by 123
Ge, L., Liu, L., Liu, H., Liu, S., Xue, H., Wang, X., Yuan, L., Wang, Z., & Liu, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.026 · Cited by 106 · cited 4×
“Resveratrol, a potent SIRT1 activator, ameliorates LPS-induced NF-κB activation in mouse hippocampus (Ge et al., 2015), and activation of SIRT1 markedly reduces NF-κB signaling and shows strong neuroprotection against amyloid β toxicity in primary cortical cultures (Chen et al., 2005).”
BackgroundInfluentialAMPK activation regulates neuronal structure in developing hippocampal neurons
Ramamurthy, S., Chang, E., Cao, Y., Zhu, J., & Ronnett, G. V. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.048 · Cited by 65 · cited 2×
“inhibits neuronal development during axon outgrowth, dendrite growth and arborization (Ramamurthy et al., 2014).”
BackgroundPark, S. Y., Choi, M. H., Li, M., Li, K., Park, G., & Choi, Y.-W. (2018) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2018.1434791 · Cited by 24 · cited 8×
“As described above, LPS treatment, which induces inflammation, decreases p-AMPK levels in cultured microglia (Li et al., 2018a; Xu et al., 2015; Park et al., 2018; Zhou et al., 2014) and also reduces p-AMPK in a mouse neuroinflammation model (Zhou et al., 2014), although it is not clear which cell…”
BackgroundMethodInfluential
Cited by
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research
Jung, E. S., Choi, H., & Mook-Jung, I. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00825-0 · Cited by 124
Stojakovic, A., Trushin, S., Sheu, A., Khalili, L., Chang, S.-Y., Li, X., Christensen, T., Salisbury, J. L., Geroux, R. E., Gateno, B., et al. (2021) · Communications Biology · doi:10.1038/s42003-020-01584-y · Cited by 72
Wang, Q., Lu, M., Zhu, X., Gu, X., Zhang, T., Xia, C., Yang, L., Xu, Y., & Zhou, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113412 · Cited by 52
Metadata
- Authors
- Saito, M., Saito, M., & Das, B. C.
- Venue
- International Journal of Developmental Neuroscience
- Publisher
- Wiley
- Published
- 2019-01-29
- Volume
- 77
- Issue
- 1
- Pages
- 48-59
- ISSN
- 0736-5748 (ISSN-L)
- 1873-474X
- OpenAlex
- W2911448712
- Cited by
- 74
- References
- 47
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.